mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.7 |
mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.7 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |